ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
M&As this week: Alexion Pharmaceutical, OvaScience
November 10, 2018Following the transaction, Syntimmune will add its clinical-stage drug candidate SYNT001 to Alexion’s portfolio.SYNT001 is a humanised monoclonal antibody (mAb) that is currently being evaluated in Phase Ib/IIa studies. -
Millendo plans to go public through OvaScience takeover, in push to complete late-stage R&D
August 10, 2018Millendo Therapeutics plans to absorb the floundering, publicly traded fertility company OvaScience into its endocrine-based rare and orphan disease efforts.
Pharma Sources Insight January 2025
